Insider Trading History of Thoma Jeanne

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Thoma Jeanne since 2021. This trader's CIK number is 1819879. At the time of last reporting, Thoma Jeanne was the Officer of Ani Pharmaceuticals Inc. (stock ticker symbol ANIP). Also see all insider trading activities at Ani Pharmaceuticals Inc.

Note that in the past Thoma Jeanne also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Avid Bioservices, Inc. (CDMO) by Thoma Jeanne

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 CDMO 0 $0 0 $0 26,756 $0
2023 CDMO 0 $0 0 $0 11,149 $0
2022 CDMO 0 $0 0 $0 1,537 $0
2021 CDMO 0 $0 0 $0 1,537 $0

Yearly summary of insider trading at Ani Pharmaceuticals Inc (ANIP) by Thoma Jeanne

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ANIP 0 $0 21,540 $1,923,845 0 $0
2021 ANIP 1,072 $49,820 0 $0 0 $0


Insider trading activities at 2 companies by Thoma Jeanne:

1. Avid Bioservices, Inc. (CDMO)

2. Ani Pharmaceuticals Inc (ANIP)

Table 1. Insider trading of Avid Bioservices, Inc. (CDMO) by Thoma Jeanne

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-12-14 CDMO Option Ex 26,756 .00 0
2023-12-14 CDMO Option Ex 9,612 .00 0
2023-12-03 CDMO Option Ex 1,537 .00 0
2022-12-03 CDMO Option Ex 1,537 .00 0
2021-12-03 CDMO Option Ex 1,537 .00 0

Table 2. Insider trading of Ani Pharmaceuticals Inc (ANIP) by Thoma Jeanne

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-18 ANIP Sale 21,540 89.31 1,923,845
2021-12-20 ANIP Buy 1,072 46.47 49,820

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thoma Jeanne (Officer of Ani Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.